Zoladex Implant
Product Images NDC 70720-951

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zoladex (NDC 70720-951). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tersera Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ter08 0000 01)

A line chart showing mean serum concentrations of goserelin (ng/ml) over time (days) after dosing with three 3.6 mg depots followed by one 10.8 mg ZOLADEX depot on day 84 in prostate cancer patients. The x-axis represents days after the first depot, and the y-axis represents mean goserelin serum concentration with standard error bars.*

FDA Label Image

Principal Display Panel (Zoladex Carton Label)

Packaging label for Zoladex 10.8 mg 3-month goserelin implant. It is a single-use syringe for subcutaneous injection, labeled for use in men with prostate cancer only. The label highlights the SafeSystem syringe with siliconized needle and includes directions for use, warnings, and manufacturer TerSera Therapeutics LLC, along with barcode and NDC 70720-951.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.